FLT1 and cancer: Vascular endothelial growth factor receptor-1 (VEGFR-1) is an ideal candidate for targeting cancer cells because it is frequently overexpressed in various human cancers such as brain, breast, prostate, kidney, ovarian, lung and bladder (Goel and Mercurio, 2013).